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Intrinsically Disordered Proteins (IDPs) are characterized by the lack of well-defined 3-D structure and
show high conformational plasticity. For this reason, they are a strong challenge for the traditional
characterization of structure, supramolecular assembly and biorecognition phenomena.We show here how
the fine tuning of protein orientation on a surface turns useful in the reliable testing of biorecognition
interactions of IDPs, in particular a-Synuclein. We exploited atomic force microscopy (AFM) for the
selective, nanoscale confinement of a-Synuclein on gold to study the early stages of a-Synuclein aggregation
and the effect of small molecules, like dopamine, on the aggregation process. Capitalizing on the high
sensitivity of AFM topographic height measurements we determined, for the first time in the literature, the
dissociation constant of dopamine-a-Synuclein adducts.
P
arkinson’s Disease (PD) is one of the most common neurodegenerative diseases that affect the 1–2% of the
population after 65 years. Motor disorders that characterize the pathology result from the substantial loss of
dopaminergic neurons in the substantia nigra and cytoplasmic fibrillaceous inclusions called Lewy bodies
(LBs) comprising a-Synuclein (AS) as major constituent are identified in post-mortem PD brains1. Due to the
preferential vulnerability of dopaminergic neurons in PD, it has been hypothesized a role for dopamine (DA) in
the biology of AS2. Lansbury et al. suggest that the formation of adducts between DA and AS stabilizes the
oligomeric, presumably toxic, protofibrillar form of the protein and inhibits the formation of AS fibrils in vitro3.
The hypothesis that protofibrils are actually the pathogenic species and that fibrils might represent a protective
cellular response is in fact consistent with pathological studies that suggest the neuroprotective role of LBs4,5. For
this reason, DA binding, stabilizing AS protofibrils, could promote PD pathogenesis6. Another important func-
tion of the DA-modified AS, recently demonstrated, is to block chaperon mediated autophagy7 although the
ensemble of function and effects in living cells is still unclear.
Structurally AS is a small presynaptic protein (14460 Da, 140 residues) that lacks of a specific structure as
reported by previous spectroscopic and NMR studies8–10. Hence, it is considered an intrinsically disordered
protein (IDP), naturally unfolded at physiological conditions. This characteristic is presumably due to the amino
acidic composition of the protein that has a high negative charge at neutral pH and low hydrophobicity11.
The sequence of the protein can be divided into three main regions: residues 1–60 that contain an imperfect
repetition of 11 residues with a conserved motif; residues 61–95, the so called NAC region, with high propensity
to the aggregation, and residues 96–140, the acidic C-terminal. AS can adopt two stable conformations:
alpha-helices when it interacts with cell membranes12,13 and beta-sheets which characterize amyloid fibrils14,15.
In both cases, the C-terminal of the protein remains unstructured, probably because of the high negative charge
content.
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Generally, the unfolded characteristics of IDPs and their propen-
sity to aggregate make them difficult to be studied with conventional,
solution-based techniques. In particular, the determination of bind-
ing affinity parameters is a challenge and, according our knowledge,
no data are available in literature. In this context, techniques based
on protein immobilization on surfaces can be a valid alternative.
Despite the limitation of surface studies, connected to the reduced
degree of freedom of the immobilized protein, they can represent a
good mean for studying IDPs, and can provide indeed important
information about the interaction with small molecules, impossible
to measure in bulk. Surface-based assays in which AS is immobilized
on a surface, have been used to studyAS: Surface PlasmonResonance
(SPR), cyclic voltammetry and standard ELISA measurements of AS
aggregation have been reported in literature16–19. In all these cases, AS
was either immobilized via physisorption or grafted on the surface
through a grafted site that is either randomly picked along the
sequence and could even be buried in the middle of the protein.
We aimed here at orienting AS on an ultraflat gold surface in a
controllable manner, via an engineered di-cysteine tag at the N-ter-
minus. We used Atomic Force Microscopy (AFM) nanolithography,
to organize AS to form nanostructures, confined into a self-assembled
monolayer of biorepellent alkanethiols ethylene glycol terminated
(EG6)20, on which promoting AS aggregation and studying its inter-
action with DA. By scanning the AFM tip locally, at high force (about
100 nN) the exchange of molecules of this carpet with the ones of our
interest in solution (e.g. di-cysteine modified AS) is favored. The
main advantage of this approach, known as nanografting21–24, is that
the molecules inside the NAnografted Monolayer (NAM) are all
oriented in the same way25. The high sensitivity of the AFM topo-
graphy permits the evaluation of small variations of patch height,
with respect to the biorepellent molecular carpet, upon binding of
other biomolecules and even small molecules. By exploiting AFM and
AFM nanografting using different assay formats, we were then able to
create AS nanoassemblies, and to give, for the first time, an estima-
tion of the binding affinity of the DA/AS agglomerates.
Results
1. AS immobilization. To allow for the oriented immobilization of
AS, we chose to engineer a specific tag at the N-terminal of the
protein. We introduced via recombinant techniques two cysteines
through which graft the protein on a gold film surface (Fig. 1). In this
way, as already demonstrated in our previous works on DNA and
protein nanografting23,25, we expected to obtain a homogeneous
distribution of orientation of AS molecules relatively to their
grafting site. However, due to the high flexibility and confor-
mational variability of this protein, even a careful orientation of AS
on the surface did not provide amean to fully control a homogeneous
distribution of conformations within the patch. Moreover, when the
protein was kept in its native state, we did not succeed in
nanografting. The reason of this can be twofold: on one side, the
unfolded nature of AS in its native state that translates into a low
diffusion coefficient; on the other side, the high conformational
plasticity of the unfolded AS that could hide the cysteine tag
engineered at the N-terminus, making the interaction between the
cysteine sulfur group and the gold surface unfeasible. Therefore, we
exploited grafting solvents that favor either alpha-helical or beta-
sheet conformation. When AS was dissolved in trifluoroethanol to
force alpha-helical conformation26, the grafting was again
unsuccessful, probably because of the increased rigidity of the
protein in correspondence of a long segment at the N-terminal27
(similarly to membrane-associated AS conformation) which did
not leave the cysteine tag free to react.
Cysteine-tagged ASmolecules were successfully immobilized only
in solvents that promoted secondary b-sheet structure of AS26. We
nanografted AS in pure methanol, with an addition of a reducing
agent (TCEP) in millimolar concentration, that keeps the di-cysteine
tag reduced and the thiols freely available to interact with gold.While
in principle disulfides adsorb on gold more efficiently with respect to
thiols, in our case protein conformation may play a major role,
hindering the disulfide-Au interaction. Even in these conditions,
however, the result of AS nanografting was variable. In particular,
it was not possible to control a priori the grafting density through the
variation of fabrication parameters, as we were used to do for
example in the case of DNA nanografting. AS nanografted assembly
was imaged in contact mode at minimum force (below 100 pN) in
buffer solution as a hole of relative height of 21.5 to 20.4 nm with
respect to the EG6 thiols SAM, whose measured height was of about
2.6 nm (Fig. S1). These values correspond in fact to a protein height
is of 1.1–2.2 nm (with respect to the gold surface), to be compared
with the effective AS theoretical value of 1.7–2.1 nm reported in
previous works28. It is reasonable to think that themolecular densities
reached in our AS nanografting experiments were generally low. In
addition, we cannot discard a compressing effect induced by the
AFM tip during imaging, despite the extremely low load applied.
Figure 1 | Schematic representation of the nanografting experiment. A self-assembled monolayer of biorepellent thiols on gold is substituted locally by
cysteine-tagged AS. The protein on the surface exposes the C-terminal that contains the specific site for DA binding (125YEMPS129), which overlaps
for one amino acid with the site (121DNEAY125) for a AS mAb (syn 211).
www.nature.com/scientificreports
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To further prove the success of AS nanografting, we observed that
both surface roughness and friction within the nanografted area were
different from the surrounding carpet, which is compatible with a
modified surface (see Fig. S2). In the experiment shown in Fig. 2, the
presence of AS grafted on the surface was confirmed by exposing the
surface to a specific mAb (8 nM, clone syn 211) able to recognize an
epitope at the C-terminal of the protein (Fig. 2 b,d).We chose a mAb
whose recognized epitope spans residues 121–125 (121DNEAY125)29,30
and overlaps for one amino acid the region of residues 125–129
(125YEMPS129), which is known to be a target for DA19, as shown
schematically in Fig. 1. The differential increase in height after
mAb binding is compatible with the average dimension of an
immunoglobulin G molecule (IgG ca 15–18 nm).
Specificity of the binding was also confirmed with a mock nano-
grafting experiment. An area was ‘‘shaved’’, i.e. the surface was nano-
grafted without the presence of additional thiol, to remove only the
preexisting SAM and the bare gold was then incubated with mAb,
which did not bind to the selected area (Fig. 3).
2. AS-DA affinity. Having proved that nanografting is an effective
way to immobilize AS in confined areas, we tested such
micropatterns as sensor to study the binding affinity with DA.
Figure 2 | AS immobilization.TheASwas nanografted in a reference thiolated SAM(a,c). The presence of the proteinwas confirmed by the loading of the
mAb and a variation in height, compatible with the size of the mAb, was recorded (b), (d). Scale bar 1 mm.
www.nature.com/scientificreports
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Figure 4 | AS-DA binding experiment. AS change morphologically and some particles appear after increasing DA binding, scale bar 500 nm (a). The
loading of DA at increasing concentration lead an evident morphological modification of the protein. This phenomenon was registered by an
average increase in the heightmeasured on five different patches. The error is the standard deviation. Fitting with a Langmuir isotherm gave a Kd 5 1.76
1.0 mM (b). The same trend is showed by roughness variation analysis. The Kd calculated is 1.4 6 1.6 mM (c).
Figure 3 | AFM nanoshaving was performed into an EG6 thiols carpet. A hole was measured by contact mode AFM in liquid (left). The sample was
incubated in presence of mAb (clone syn 211) for two hour. AFM imaging suggest no relevant variation in the shaved surface (right), meaning
that no aspecific interaction with gold occurred.
www.nature.com/scientificreports
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This neurotransmitter is known to interact with residues 120–125 in
the C-term tail of the protein, and simultaneously with residues in
the NAC region as long-range contact that may stabilize the bound
conformation31,32.
2.1. AS nanostructures to study DA-AS affinity. In order to estimate
DA-AS binding affinity, we build a binding assay, measuring the
topographical variations of AS nanografted patches incubated with
increasing concentration of DA.
An average increase in height, though very moderate, could be
recorded, possibly due to an increased rigidity of AS upon DA bind-
ing and therefore to an increased resistance to the AFM tip load.
More interestingly, the roughness of the nanografted area showed an
increase, related to DA binding (Fig. 4). Inspection of the AFM
images shows the presence of particles that do not increase in num-
ber (they are the same throughout the experiment) upon DA dosing.
We analyzed the binding of DA to AS through a sigmoidal dose
response of the patch height, obtaining an apparent dissociation
constant in the micromolar range (Kd 5 1.7 6 1.0 mM) (Fig. 4b).
The same fitting was performed on the roughness variation data,
confirming the same trend (Kd 5 1.4 6 1.6 mM) (Fig. 4c). After
loading ofDA, the sample was treated with nanomolar concentration
ofmAb syn211 that, as already said, recognizes epitope 121DNEAY125,
which overlap for one amino acid (Y125) to the DA binding site. The
height of the patches upon mAb loading increases, suggesting that
the surface is still covered by the protein with the binding site
exposed to the liquid-solid interface, in agreement with previous
studies19. The measured height (3.3 nm over the AS nanografted
patch, Fig. 5) is however lower than expected (Fig. 2 b,d), probably
due to the aspecific binding of the mAb.
2.2. mAb-DA displacement assay. AS nanografted patches are recog-
nized bymAb syn211 that binds epitope 121DNEAY125, which overlap
for one aminoacid (Y125) to the binding site of DA. This specific
mAb was chosen among the many available for its capacity of bind-
ing the C-term chain of AS and because of the vicinity of the epitope
to theDAbinding site. In fact, though theDAbinding site overlap for
only one amino acid, there is a chance that the conformational
change due to the short and long range interaction of DA with
125YEMPS129 and residues in the NAC region destabilizes the binding
site of the mAb, as is indeed observed experimentally (Fig. 6a). For
this reason, we called it as ‘‘displacement assay’’. Since small mole-
cules, like DA, need very precise instrument in order to register their
binding, we used the displacement assay to confirm the data obtained
in the direct binding assay. In this case, bigger height variations,
relatively easy to be measured, can give a more precise estimation
of the binding constant. In this assay, the immobilized AS was incu-
Figure 5 | AS-DA patches recognize themAb. The AS nanografted patches were treated with 10 mMDA (a). The patches where then incubated with nM
concentration of the mAb (b). The topography of the surface increases but it is less than expected (c).
www.nature.com/scientificreports
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bated with DA in the presence of the mAb and the saturated surface
was analyzed by AFM topography variations.
After DA addition at increasing concentration, the patches show a
decrease in height due to the partial displacement of mAb molecules
over the patch (Fig. 6b). A control experiment performed incubating
the mAb/AS patches in presence of the bare buffer only (no DA),
does not show any height decrease (see Fig. S3). Our speculation is
that probably the conformational change occurring upon binding to
DA, due to long range interactions, can destabilize the AS/mAb
binding. This hypothesis is supported by theoretical modeling (see
supporting informations) that suggests a weak interaction of AS with
the YEMPS site, and therefore a key role of long range interactions in
the stabilization of DA binding.
Plotting themeasured absolute height (normalized over the height
of mAb saturated AS patches) vs DA concentration, we obtain an
inverted Langmuir isotherm fromwhich it is possible to calculate the
Kd value as the concentration of DA that causes half-maximal dis-
placement of themAb. The value obtained of 3.96 1.6 mMis in good
agreement with the experimental Kd calculated in the direct assay
previously described. As observed by the data plot, at saturation the
mAb is not completely displaced from the surface. This phenomenon
suggests that some mAb are interacting with AS through nonspecific
binding sites, as suggested also by the previous experiment (Fig. 5b).
3. AS nanostructures to promote the supramolecular assembly
formation and to study the effect of DA on them. Finally, results
about the potential use of this assay to study the early stages of the AS
aggregation are presented. In this case, AS nanografted patches
(Fig. 7a) were incubated with a solution containing recombinant
AS to promote AS aggregation. We observed a time-dependent
topographic height increase over the AS patches versus incubation
time (24–48–72 hours, Fig. 7 b, c, d) suggesting a local interaction
between AS molecules. The addition of highly concentrated DA
(20 mM, close to the saturation point) disrupts these aggregates
after 30 minutes incubation, probably stabilizing small oligomers,
observable as round spheres by AFM imaging (Fig. 7e). Further
addition of AS molecules plus DA after DA treatment does not
show any increase in patch height after 24 hours incubation,
confirming the stable binding of DA on the protein (Fig. 7f). The
analysis of the roughness of the patches confirms the formation of
aggregates on the surface (Fig. 7h). These data support the hypothesis
that DA and its oxidation products, such as dopaminochrome,
interacting with the 125YEMPS129 region, inhibit the formation of
AS aggregates. This could suggest that DA binding causes a
conformational rearrangement in the AS molecules, due to the
interaction with distal residues at the N-terminal, leading to an off-
pathway intermediate, unable to produce aggregates.
Discussion
AS is part of a family of proteins called IDPs. They are characterized
by a total or partial lack of a three dimensional conformation and are
prone to aggregation. These unfolded characteristics make difficult
the study of these proteins with conventional techniques. In this
work, we demonstrated that nanografting is a useful tool to immob-
ilize AS and study the interactions that affect these proteins. The
orientation of the molecules on a confined surface and the high
precision in the AFM measurements, permitted the calculation of
the affinity between AS and small molecules like DA speculating a
conformational rearrangement of the protein during this process.
We were also able to calculate for the first time the dissociation
constant between AS and DA that is in the micromolar range.
Once we demonstrated a competition between DA and the mAb
(clone syn 211) to bind to AS, probably due to the close proximity
and the partial overlapping of the two binding sites, our assay was
exploited also for displacement studies. The observed partial dis-
placement of the mAb from its AS binding site upon DA incubation
was attributed to a rearrangement of the three dimensional structure
Figure 6 | mAb-DAdisplacement assay. (a). AS patches recognized by themAb are incubatedwith 1 mMDA. The displacement of themAb ismonitored
as a decrease in height. (b). The plot reports the average of the absolute heights H of five AS grafted patches during the experiment normalized with
respect H0, the initial height of the patches after mAb incubation, vs DA concentration. Fitting with an inverted Langmuir isotherm gave a
Kd 5 3.9 6 1.6 mM. The error is the standard deviation.
www.nature.com/scientificreports
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of the protein due to effective interaction of DA on the expected
binding site 125YEMPS129 and to long-range interactions. Our dis-
placement assay gave us the possibility to measure the AS-DA bind-
ing affinity from large topographic height variation signals, relatively
easy to be measured by AFM. This assay confirmed the micromolar
dissociation constant calculated in the direct assay, supporting the
validity and the precision of our technique for binding studies of
small molecules. With the help of the theoretical modeling, we
explored the role of the 125YEMPS129 site of AS in the binding with
DA. We observed that the theoretical dissociation constant is higher
than the experimental one (from mM to mM). These results
strengthen the hypothesis that non-covalent contacts with residues
of the NAC region, stabilizing the AS/DA adduct increase the affinity
of the binding.
Finally, we demonstrated that our assay could represent a valid
alternative for the study of the early stages of the aggregation process.
In particular, our approach was used to confirm the effect of dopa-
mine on these structures, able to dissolve self-associated AS.
In conclusion, we demonstrated that the combination of AFM
nanografting and topographic readout is a valid tool for the deter-
mination of the affinity binding of unstructured proteins, such as AS,
with small molecules and for testing the effect of small molecules on
the early stages of the aggregation process.
Methods
Materials and instrumentation. EG6-thiols, HS-(CH2)11-(OCH2CH2)6-OH, were
purchased from Prochimia Surfaces (Poland). KCl, TRIS (2-Amino-2-
hydroxymethyl-propane-1,3-diol), TCEP (tris(2-carboxyethyl)phosphine), sodium
acetate, methanol and ethanol (99.8% purity) were all provided by Fluka and Sigma
Aldrich, (Milan, Italy). All the solutions were prepared in ultrapure 18.2 MV?cm
water (Milli-Q, Millipore SpA, Milan, Italy), and filtered with a sterile syringe-filter
(0.22 mm) prior to use. All other reagents were of analytical grade. All AFM
experiments were carried out with conventional AFMs using a XE-100 (Park System,
former PSIA, Korea) and a MFP3D Stand Alone AFM, (Asylum Research, Santa
Barbara, CA) working in contact mode. For nanografting commercially available
silicon cantilevers (NSC19, Mikro- Masch, Poland, nominal spring constant 0.6 nN/
nm, tip radius ,10 nm) were chosen. For CM-AFM imaging purposes, a soft
cantilever (CSC38B, MikroMasch, Poland, nominal spring constant, 0.03 nN/nm, tip
radius ,10 nm) was used.
Substrate and monolayer preparation. An ultra-flat gold surface was prepared
following the Template Stripped Gold (TSG) procedure described by Wagner et al33.
Briefly, a layer of gold was evaporated on freshly cleaved mica sheets (clear ruby
muscovite, Goodfellow Cambridge Limited, Huntingdon, England) or on a Si(100)
wafer using an electron beam gold evaporator. Gold films were deposited at a rate of
,0.1 nm/s and a chamber pressure of about 1026 mbar until a thickness of 100 nm
Figure 7 | AS patches were incubated in presence of AS. The surface was monitored over time by topographic AFM measurement (a), (b), (c), (d).
Finally, the effect of DA was evaluated. DA interacts with the AS self-association site disrupting the aggregates formed in 72 hours, stabilizing small
oligomers (e). Such binding is stable and prevents the self-association in presence of AS molecules also after 24 hours of incubation (f). The aggregation
process and the disaggregation are reflected by the topography (g) and the roughness (h) of the surface. The values are calculated as the average of five
different patches, the error is the standard deviation. Scale bar 500 nm.
www.nature.com/scientificreports
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was reached. These films were fixed to Si(100) wafer pieces with a drop of SU8-100
(MicroChem Corp., MA), and the polymer was then cured (baked 5 h at 95uC,
exposed 20 min under a 70 mW/cm2, 462 nm UV lamp, and baked at least 3 hours at
95uC). They were then separated at the gold–mica (or gold-Si) interface by peeling
immediately before functionalization. This proceduremade gold substrates with a flat
surface morphology, reproducing the atomically flat mica surface. Samples are then
soaked in a freshly prepared 300 mM solution of EG6-terminated thiols in ethanol.
The substrates were incubated overnight in the dark at room temperature. In this way,
a self-assembled monolayer (SAM) of thiolated molecules covers the ultra-flat gold
surface. AFM test measurements confirmed a roughness of the substrate in the range
of 0.3–0.4 nm.
RecombinantDi-CysteineAS expression and purification. In order to removemost
tags at the end of the purification process, we used Profinity eXactTM0 fusion-tag
system (Bio-Rad Laboratories, Hercules, Calif.) which uses an immobilized
subtilisin protease to carry out affinity binding and tag cleavage to produce Di-
Cysteine AS. The human AS cDNA was isolated by pUC57-a-syn vector purchased
by GenScript. The following primers were used: 59 CGAAAGCTTTGACTTCT
TGCTGCGATGTATTC ATGAAAGG 39 containing nucleotides coding for Thr-Ser
linker to obtain an optimal cleavage during the purification step, nucleotides coding
for two Cys and restriction site for Hind III and 39 TACCCATGGTTAGGCT-
TCAGGTTCGTAGTCTT 59 containing the restriction site for NcoI. The a-Syn
cDNA was cloned into the Hind III and NcoI restriction sites of the bacterial
expression vector pPAL7. BL21(DE3) E. coliwere transfected with pPAL7/Cys-a-syn
plasmid, and expression was induced by the addition of isopropyl b-D-
thiogalactopyranoside (IPTG). Cells were harvested, resuspended in 10 mMTris, pH
8, 1 mM EDTA, 1 mM PMSF (1/10 culture volume), and lysed by freezing in liquid
nitrogen followed by thawing and probe sonication. The di-Cyst AS protein was
purified by size-exclusion chromatography (Superdex 200 10/300 GL, Amersham
Bioscences) with 50 mM sodium phosphate buffer pH 7.4, 300 mM NaCl. After the
collected fraction was purified by using Profinity exact resin (Bio-Rad Laboratories,
Hercules, Calif.). The protein purified was verified by SDS PAGE 2–15% and then
lyophilized. Di-Cyst AS protein was determinated to be ca. 97% pure by SDS-PAGE.
AFM Nanografting and imaging. Nanografting experiments were performed as
follows: a freshly SAM passivated gold substrate was rinsed with ethanol and fixed in
an AFM closed liquid cell. The gold surface was scratched with a worn out AFM tip to
have a recognition point onto the surface to facilitate finding back the nanostructures.
The liquid cell was filled with the nanografting solution that contains 3 mM cysteine-
tagged AS in methanol with the addition of 1 mM TCEP dissolved in methanol. The
patches were obtained scanning the desired area at high load (about 100 nN) and at a
scan rate about 2 Hz. In this way local excange between the EG6-thiolated molecules
and the protein in solution is promoted. During nanografting procedure, patches of
about 1 mm2 (512 3 512 pixels) were fabricated. The liquid cell was abundantly
washed with 10 mM TRIS, 150 mM KCl, pH 7.4 after the incubation time of every
step of the experiments. The imaging was performed in contact mode in the same
buffer at minimum load forces (below 100 pN).
Dopamine (DA) binding. Dopamine (Sigma Aldrich) was freshly dissolved and
incubated with increasing concentration (from 10 nM to 10 mM) in buffer 20 mM
sodium acetate, 150 mM KCl pH 5.5, to minimize auto-oxidation. The differential
height was used as the response signal and fitted to a Langmuir isotherm35, that
describes the binding of a ligand to amacromolecule, in Igor Pro (Wavemetrics, Inc.).
The topographic measurements were performed after 30 minutes incubation, time
sufficient for the diffusion and the binding of the DA. A mAb (8 nM, syn clone 211,
SigmaAldrich)29 was used to recognize AS patches. The antibodywas diluted in buffer
10 mM TRIS, 150 mM KCl, pH 7.4 and incubated for 2 hours.
Displacement assay. Nanografted AS patches were incubated in presence of a
solution of the mAb (syn clone 211, Sigma Aldrich)29 8 nM, dissolved in 10 mM
TRIS, 150 mM KCl, pH 7.4 and incubated for two hours. The topographic
measurements were performed after 30 minutes incubation, time sufficient for the
diffusion and the binding of the DA. The differential height was used as the response
signal and fitted to an inverted Langmuir isotherm35, that describes the non-
competitive binding of a second ligand to a macromolecule, in Igor Pro
(Wavemetrics, Inc.).
AS self-association. Recombinant human AS histine-tagged (Sigma Aldrich) was
freshly dissolved at 3.5 mM concentration in buffer 10 mM TRIS, 150 mM KCl, pH
7.4. As reported in literature the presence of the histidine does not affect significantly
the AS aggregation34. AS nanografted patches were incubated in presence of the
histidine tagged AS at different times (24, 48, 72 hours). 20 mM DA was added and
incubated for 30 minutes over the self-associated AS patches. The further addition of
3.5 mMAS in presence of DA for 24 hours did not increase the height of the patches.
Images analysis. For each experiment were fabricated multiple patches that
contribute to the experiment statistic. For every patch the average height was
calculated from the average profile and together with the standard deviation.
Topographic images of the patches are then analyzed in term of pixel distribution
(region analysis) in order to get the height value related to the patch at each single step
of the experiments. The AFM instrument proprietary software (XEI, Park System,
and MFP3D, Asylum Research) as well as free open source software, Gwyddion
(www.gwyddion.net), were used.
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